Antiphospholipid Syndrome
"Antiphospholipid Syndrome" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The presence of antibodies directed against phospholipids (ANTIBODIES, ANTIPHOSPHOLIPID). The condition is associated with a variety of diseases, notably systemic lupus erythematosus and other connective tissue diseases, thrombopenia, and arterial or venous thromboses. In pregnancy it can cause abortion. Of the phospholipids, the cardiolipins show markedly elevated levels of anticardiolipin antibodies (ANTIBODIES, ANTICARDIOLIPIN). Present also are high levels of lupus anticoagulant (LUPUS COAGULATION INHIBITOR).
| Descriptor ID |
D016736
|
| MeSH Number(s) |
C20.111.197
|
| Concept/Terms |
Antiphospholipid Syndrome- Antiphospholipid Syndrome
- Syndrome, Antiphospholipid
- Hughes Syndrome
- Syndrome, Hughes
- Antiphospholipid Antibody Syndrome
- Antibody Syndrome, Antiphospholipid
- Antiphospholipid Antibody Syndromes
- Syndrome, Antiphospholipid Antibody
- Anti-Phospholipid Antibody Syndrome
- Anti Phospholipid Antibody Syndrome
- Antibody Syndrome, Anti-Phospholipid
- Syndrome, Anti-Phospholipid Antibody
- Anti-Phospholipid Syndrome
- Anti Phospholipid Syndrome
- Syndrome, Anti-Phospholipid
|
Below are MeSH descriptors whose meaning is more general than "Antiphospholipid Syndrome".
Below are MeSH descriptors whose meaning is more specific than "Antiphospholipid Syndrome".
This graph shows the total number of publications written about "Antiphospholipid Syndrome" by people in this website by year, and whether "Antiphospholipid Syndrome" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 1 | 2 |
| 1997 | 1 | 1 | 2 |
| 1998 | 0 | 1 | 1 |
| 1999 | 1 | 0 | 1 |
| 2000 | 1 | 1 | 2 |
| 2003 | 1 | 0 | 1 |
| 2004 | 1 | 0 | 1 |
| 2008 | 2 | 0 | 2 |
| 2009 | 2 | 1 | 3 |
| 2015 | 0 | 1 | 1 |
| 2017 | 0 | 1 | 1 |
| 2018 | 1 | 0 | 1 |
| 2019 | 1 | 1 | 2 |
| 2021 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Antiphospholipid Syndrome" by people in Profiles.
-
Protein Phosphatase 2A Activation Via ApoER2 in Trophoblasts Drives Preeclampsia in a Mouse Model of the Antiphospholipid Syndrome. Circ Res. 2021 09 17; 129(7):735-750.
-
Pathogenic lipid-binding antiphospholipid antibodies are associated with severity of COVID-19. J Thromb Haemost. 2021 09; 19(9):2335-2347.
-
Use of combined hormonal contraceptives among women with systemic lupus erythematosus with and without medical contraindications to oestrogen. Rheumatology (Oxford). 2019 07 01; 58(7):1259-1267.
-
Platelet Activation by Antiphospholipid Antibodies Depends on Epitope Specificity and is Prevented by mTOR Inhibitors. Thromb Haemost. 2019 Jul; 119(7):1147-1153.
-
A Man with Severe Pulmonary Hypertension and Right Ventricular Failure. Ann Am Thorac Soc. 2018 12; 15(12):1472-1476.
-
Anti-phospholipid Antibodies and Smoking: An Overview. Clin Rev Allergy Immunol. 2017 Aug; 53(1):1-13.
-
Antiphospholipid Antibodies and Recurrent Thrombotic Events: Persistence and Portfolio. Cerebrovasc Dis. 2015; 40(5-6):293-300.
-
Plasmin immunization preferentially induces potentially prothrombotic IgG anticardiolipin antibodies in MRL/MpJ mice. Arthritis Rheum. 2009 Oct; 60(10):3108-17.
-
Patent foramen ovale, cardiac valve thickening, and antiphospholipid antibodies as risk factors for subsequent vascular events: the PICSS-APASS study. Stroke. 2009 Jul; 40(7):2337-42.
-
Interferon-alpha treatment of female (NZW x BXSB)F(1) mice mimics some but not all features associated with the Yaa mutation. Arthritis Rheum. 2009 Apr; 60(4):1096-101.